Trial intelligence / Profile preview

Pyridoxal-phosphate for Primary Hyperoxaluria Type I

NCT01281878Phase 2Completed

Sponsor
University of Cologne
Start
Dec 2010
Primary completion
Sep 2012
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of pyridoxal-5'-phosphate in Primary Hyperoxaluria Type 1 (PH1), sponsored by University of Cologne. Started Dec 2010; status: completed.

02

Drugs

pyridoxal-5'-phosphate
03

Conditions

Primary Hyperoxaluria Type 1 (PH1)

Beyond the preview

Go deeper on NCT01281878.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01281878.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call